Philip Savage
Philip Savage
Medical Oncologist
Verified email at
Cited by
Cited by
Prognostic markers and long-term outcome of placental-site trophoblastic tumours: a retrospective observational study
P Schmid, Y Nagai, R Agarwal, B Hancock, PM Savage, NJ Sebire, ...
The Lancet 374 (9683), 48-55, 2009
EMA/CO for high-risk gestational trophoblastic neoplasia: good outcomes with induction low-dose etoposide-cisplatin and genetic analysis
C Alifrangis, R Agarwal, D Short, RA Fisher, NJ Sebire, R Harvey, ...
Journal of clinical oncology 31 (2), 280-286, 2013
Malignant ovarian germ cell tumors: identification of novel prognostic markers and long-term outcome after multimodality treatment
N Murugaesu, P Schmid, G Dancey, R Agarwal, L Holden, I McNeish, ...
Journal of clinical oncology 24 (30), 4862-4866, 2006
Identification of 13 novel NLRP7 mutations in 20 families with recurrent hydatidiform mole; missense mutations cluster in the leucine-rich region
CM Wang, PH Dixon, S Decordova, MD Hodges, NJ Sebire, S Ozalp, ...
Journal of medical genetics 46 (8), 569-575, 2009
Treatment outcomes for 618 women with gestational trophoblastic tumours following a molar pregnancy at the Charing Cross Hospital, 2000–2009
A Sita-Lumsden, D Short, I Lindsay, NJ Sebire, D Adjogatse, MJ Seckl, ...
British journal of cancer 107 (11), 1810-1814, 2012
Salvage chemotherapy of relapsed or high-risk gestational trophoblastic neoplasia (GTN) with paclitaxel/cisplatin alternating with paclitaxel/etoposide (TP/TE)
J Wang, D Short, NJ Sebire, I Lindsay, ES Newlands, P Schmid, ...
Annals of Oncology 19 (9), 1578-1583, 2008
The effects of trastuzumab on the CD4+ CD25+ FoxP3+ and CD4+ IL17A+ T-cell axis in patients with breast cancer
C Horlock, B Stott, PJ Dyson, M Morishita, RC Coombes, P Savage, ...
British journal of cancer 100 (7), 1061-1067, 2009
Granulosa cell tumours of the ovary: demographics, survival and the management of advanced disease
P Savage, D Constenla, C Fisher, JH Shepherd, DPJ Barton, P Blake, ...
Clinical Oncology 10 (4), 242-245, 1998
Why does cytotoxic chemotherapy cure only some cancers?
P Savage, J Stebbing, M Bower, T Crook
Nature Clinical Practice Oncology 6 (1), 43-52, 2009
The relationship of maternal age to molar pregnancy incidence, risks for chemotherapy and subsequent pregnancy outcome
PM Savage, A Sita-Lumsden, S Dickson, R Iyer, J Everard, R Coleman, ...
Journal of Obstetrics and Gynaecology 33 (4), 406-411, 2013
A phase I clinical trial of imiquimod, an oral interferon inducer, administered daily
P Savage, V Horton, J Moore, M Owens, P Witt, ME Gore
British journal of cancer 74 (9), 1482-1486, 1996
A comparison of patients with relapsed and chemo-refractory gestational trophoblastic neoplasia
T Powles, PM Savage, J Stebbing, D Short, A Young, M Bower, C Pappin, ...
British journal of cancer 96 (5), 732-737, 2007
The management and outcome of women with post-hydatidiform mole ‘low-risk’gestational trophoblastic neoplasia, but hCG levels in excess of 100 000 IU l− 1
S McGrath, D Short, R Harvey, P Schmid, PM Savage, MJ Seckl
British Journal of Cancer 102 (5), 810-814, 2010
Plasma kisspeptin is raised in patients with gestational trophoblastic neoplasia and falls during treatment
WS Dhillo, P Savage, KG Murphy, OB Chaudhri, M Patterson, GM Nijher, ...
American Journal of Physiology-Endocrinology and Metabolism 291 (5), E878-E884, 2006
Risk of recurrent molar pregnancies following complete and partial hydatidiform moles
N Eagles, NJ Sebire, D Short, PM Savage, MJ Seckl, RA Fisher
Human reproduction 30 (9), 2055-2063, 2015
The demographics of molar pregnancies in England and Wales from 2000–2009
P Savage, J Williams, SL Wong, D Short, S Casalboni, K Catalano, ...
J Reprod Med 55 (7-8), 341-5, 2010
Relapse rates after two versus three consolidation courses of methotrexate in the treatment of low-risk gestational trophoblastic neoplasia
C Lybol, F Sweep, R Harvey, H Mitchell, D Short, CMG Thomas, ...
Gynecologic oncology 125 (3), 576-579, 2012
Acute phase proteins, C-reactive protein and serum amyloid A protein, as prognostic markers in the elderly inpatient
MB Hogarth, JR Gallimore, P Savage, AJ Palmer, JM Starr, CJ Bulpitt, ...
Age and ageing 26 (2), 153-158, 1997
The impact of molecular genetic diagnosis on the management of women with hCG-producing malignancies
RA Fisher, PM Savage, C MacDermott, J Hook, NJ Sebire, I Lindsay, ...
Gynecologic oncology 107 (3), 413-419, 2007
A phase 1 study of AS1409, a novel antibody-cytokine fusion protein, in patients with malignant melanoma or renal cell carcinoma
SM Rudman, MB Jameson, MJ McKeage, P Savage, DI Jodrell, M Harries, ...
Clinical Cancer Research 17 (7), 1998-2005, 2011
The system can't perform the operation now. Try again later.
Articles 1–20